More Novartis layoffs

Share this article:

Novartis is continuing its cost-cutting streak. Reuters reports that the drugmaker is planning on cutting and relocating up to 4,000 jobs, according to an internal email held by newspaper NZZ am Sonntag.

Sunday's news follows a spate of other layoffs at the drugmaker, including the recent closure of an Ontario, Canada, plant, and the company's decision to shake off some California jobs and move others to Massachusetts.

Reuters says this latest round will inflict pink slips on around 6% of employees in the Swiss drug maker's pharmaceutical division and that “a significant number” of jobs will be moved to Hyderabad, India, as part of a consolidation strategy.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.